Clinical trials
Phase 1/2 Non-alcoholic Fatty Liver Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 6 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Terminated | 4 |
| Unknown status | 4 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sadat City University | 3 |
| Regeneron Pharmaceuticals | 2 |
| 1Globe Biomedical Co., Ltd. | 1 |
| 89bio, Inc. | 1 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Adrian Vella | 1 |
| Amira Bisher,PhD | 1 |
| Arrowhead Pharmaceuticals | 1 |
| AstraZeneca | 1 |
| Bambino Gesù Hospital and Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 36 |
| Fatty Liver | 10 |
| Obesity | 7 |
| Liver Cirrhosis | 5 |
| Fibrosis | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| Liver Diseases | 3 |
| Diabetes Mellitus | 2 |
| Metabolic Diseases | 2 |
| Overweight | 2 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.